About OraPharma
OraPharma is a company based in Bridgewater (United States) founded in 1997 was acquired by Bausch Health in June 2012.. OraPharma has raised $16 million across 1 funding round from investors including Bausch Health, Frazier Healthcare Partners and Canaan. OraPharma offers products and services including Arestin and OSSIX Portfolio. OraPharma operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Bridgewater, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Orapharma Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16 M (USD)
in 1 rounds
-
Latest Funding Round
$16 M (USD), Series C
Dec 14, 1998
-
Investors
Bausch Health
& 7 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OraPharma
OraPharma offers a comprehensive portfolio of products and services, including Arestin and OSSIX Portfolio. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Antibacterial microspheres for managing gum disease in patients.
Regenerative materials for bone and tissue grafting procedures.
Unlock access to complete
Unlock access to complete
Software Development Team
294 people
Leadership Team
141 people
Senior Team
50 people
Finance and Accounting
45 people
Data Analysis and Operations Team
41 people
Product Management Team
26 people
Legal and Compliance
26 people
Human Resources and Administration
26 people
Unlock access to complete
Funding Insights of OraPharma
OraPharma has successfully raised a total of $16M through 1 strategic funding round. The most recent funding activity was a Series C round of $16 million completed in December 1998. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $16.0M
-
First Round
First Round
(14 Dec 1998)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 1998 | Amount | Series C - OraPharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OraPharma
OraPharma has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Bausch Health, Frazier Healthcare Partners and Canaan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Founded Year | Domain | Location | |
|
Early-stage companies are invested in globally by TL Ventures.
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OraPharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OraPharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orapharma Comparisons
Competitors of OraPharma
OraPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Orapharma
Frequently Asked Questions about OraPharma
When was OraPharma founded?
OraPharma was founded in 1997 and raised its 1st funding round 1 year after it was founded.
Where is OraPharma located?
OraPharma is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
Is OraPharma a funded company?
OraPharma is a funded company, having raised a total of $16M across 1 funding round to date. The company's 1st funding round was a Series C of $16M, raised on Dec 14, 1998.
What does OraPharma do?
OraPharma is developing products that help improve and maintain oral health. ARESTIN (minocycline HCl) Microspheres, 1 mg is a locally administered antibiotic (LAA) offering a patented microsphere technology for the treatment of periodontitis as an adjunct to scaling and root planing. Another product ONSET, a delivery system of locally buffered anesthesia that can provide faster onset of anesthesia and more comfortable injection. Other products include EZ white for whitening, ossix plus for tissue regeneration, and neutrasal for dryness of oral mucosa.
Who are the top competitors of OraPharma?
OraPharma's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does OraPharma offer?
OraPharma offers Arestin and OSSIX Portfolio.
Who are OraPharma's investors?
OraPharma has 8 investors. Key investors include Bausch Health, Frazier Healthcare Partners, Canaan, TL Ventures, and Domain Associates.